Select your language
28.07.2026
Tuberculosis remains the world’s deadliest infectious disease caused by a single pathogen. In 2024, an estimated 10.7 million people worldwide developed tuberculosis, and 1.23 million died from the disease. The situation is particularly critical for drug-resistant tuberculosis: only around two in five affected individuals had access to treatment in 2024. Moreover, treatment outcomes remain substantially poorer than for drug-susceptible tuberculosis.
24.07.2026
The first online lecture series on infectious diseases organized as part of the BREATHE project concluded with an interactive “Infectious Diseases Jeopardy” quiz. Dr Diana Udovenko achieved the highest score and received a Littmann stethoscope in recognition of her quick and precise answers.
21.07.2026
A team from the University of Bonn and the Research Center Borstel, Leibniz Lung Center (FZB) has discovered a previously unknown mechanism of action for a synthetic peptide that mitigates excessive inflammatory responses in allergic asthma. This mechanism specifically inhibits a key inflammatory switch in the immune system and opens up new avenues for treating chronic inflammatory diseases. The findings have now been published in the journal Advanced Science.
7. - 9. September 2026
Borstel
28.-29.09.2026Medical Campus of the University of Cologne, Germany
5. November 2026Borstel
